Paper Details

  1. Home
  2. Paper Details

Rotigotine Transdermal Patch Improves Swallowing in Dysphagic Patients with Parkinson's Disease.

Author: HiranoMakito, IsonoChiharu, KusunokiSusumu, NakamuraYusaku, SakamotoHikaru, UenoShuichi

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Rotigotine, a dopamine agonist, has been shown to improve swallowing in patients with Parkinson's disease (PD) who experience dysphagia, a potentially fatal symptom that can lead to aspiration pneumonia.
Paper Details　
Original Abstract of the Article :
Abnormal swallowing, dysphagia, is a potentially fatal symptom in Parkinson's disease (PD) and is characterized by frequent silent aspiration, an unrecognized risk of suffocation and aspiration pneumonia. Several studies have reported that the injection of apomorphine, a dopamine agonist, alleviated...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s00455-015-9622-5

データ提供：米国国立医学図書館（NLM）

Swallowing Difficulties in Parkinson's Disease: A New Treatment Approach

Parkinson's disease, a neurological condition that affects movement, can also impact swallowing, leading to a condition called dysphagia. This study, published in the journal [論文掲載誌], explores the potential of rotigotine, a dopamine agonist, for improving swallowing in Parkinson's patients.

Rotigotine: A Potential Solution for Dysphagia

Think of the desert as a vast landscape where water sources are essential for survival. Similarly, the brain's dopamine system plays a vital role in regulating movement and swallowing. In this study, the researchers investigated the use of rotigotine, a dopamine agonist delivered through a transdermal patch, as a treatment for dysphagia in Parkinson's patients. They found that rotigotine significantly improved swallowing function, offering a non-invasive treatment option for patients with this debilitating condition.

Improving Quality of Life for Parkinson's Patients

This research provides a glimmer of hope for Parkinson's patients who struggle with dysphagia. The findings suggest that rotigotine could improve the quality of life for these patients by reducing the risk of choking and aspiration pneumonia. As Dr. Camel, I am encouraged by the prospect of new treatments that can address the multifaceted challenges faced by people living with Parkinson's disease.

Dr.Camel's Conclusion

This study sheds light on the potential of rotigotine as a non-invasive treatment for dysphagia in Parkinson's disease. The researchers' findings offer hope for improving the quality of life for patients struggling with this challenging condition. As research continues to advance, we can expect to see more innovative approaches to address the diverse needs of individuals living with Parkinson's disease.
Date :
  1. Date Completed 2016-10-20
  2. Date Revised 2022-03-31
Further Info :

Pubmed ID

25966655

DOI: Digital Object Identifier

10.1007/s00455-015-9622-5

Related Literature

Article Analysis
・Effects of rotigotine transdermal patch
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.